✦ LIBER ✦

Clinical trials with aldose reductase inhibitors

✍ Scribed by D. Stribling

Book ID: 115894041
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 512 KB
Volume: 50
Category: Article
ISSN: 0014-4835
DOI: 10.1016/0014-4835(90)90103-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recent clinical experience with aldose r

Recent clinical experience with aldose reductase inhibitors

✍ H.M.J. Krans 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 678 KB

Current progress in clinical trials of a

Current progress in clinical trials of aldose reductase inhibitors in Japan

✍ N. Hotta; H. Kakuta; F. Ando; N. Sakamoto 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Clinical experience with sorbinil—An ald

Clinical experience with sorbinil—An aldose reductase inhibitor

✍ Norman E. Pitts; Franzanne Vreeland; Gerald L. Shaw; Michael J. Peterson; Dilip 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 521 KB

Clinical Potential of Aldose Reductase I

Clinical Potential of Aldose Reductase Inhibitors in Diabetic Neuropathy

✍ Dr Yoji Hamada, Jiro Nakamura 📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 142 KB

Aldose reductase inhibitors and cataract

✍ M. James C. Crabbe 📂 Article 📅 1991 🏛 Springer Netherlands 🌐 English ⚖ 910 KB

Blindness in diabetics is largely due to retinopathy and/or cataract. Hyperglycaemia and the duration of diabetes are major risk factors for the development of cataract and retinopathy. This review details some of the reactions of glucose that are relevant to the development of complications, and fo

S-4-7 Clinical trial of aldose reductase

S-4-7 Clinical trial of aldose reductase inhibitor (ONO-2235) on diabetic retinopathy

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 72 KB